Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Canada publishes guidances on new regulations:

This article was originally published in Clinica

Executive Summary

Canada's Therapeutic Products Programme has published three draft guidance documents on the country's new medical device regulations, which are due to come into effect on July 1. The documents - on the interpretation of significant change, how to determine the device licence type and the handling of device complaints and recalls - are available at the TPP's website on http://www.hc-sc.ca/hpb-dgps/therapeut/drhtmeng/

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT080750

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel